Exact Mass: 356.0831

Exact Mass Matches: 356.0831

Found 202 metabolites which its exact mass value is equals to given mass value 356.0831, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sulindac

2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid

C20H17FO3S (356.0882)


Sulindac is a nonsteroidal anti-inflammatory agent (NSAIA) of the arylalkanoic acid class that is marketed in the U.S. by Merck as Clinoril. Like other NSAIAs, it may be used in the treatment of acute or chronic inflammatory conditions. Sulindac is a prodrug, derived from sulfinylindene, that is converted in vivo to an active sulfide compound by liver enzymes. The sulfide metabolite then undergoes enterohepatic circulation; it is excreted in the bile and then reabsorbed from the intestine. This is thought to help maintain constant blood levels with reduced gastrointestinal side effects. Some studies have shown sulindac to be relatively less irritating to the stomach than other NSAIAs except for drugs of the cyclooxygenase-2 (COX-2) inhibitor class. The exact mechanism of its NSAIA properties is unknown, but it is thought to act on enzymes COX-1 and COX-2, inhibiting prostaglandin synthesis. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents KEIO_ID S054; [MS2] KO009077 KEIO_ID S054; [MS3] KO009079 D004791 - Enzyme Inhibitors KEIO_ID S054

   

5-Amino-6-(5'-phosphoribitylamino)uracil

{[(2R,3S,4S)-5-[(5-amino-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino]-2,3,4-trihydroxypentyl]oxy}phosphonic acid

C9H17N4O9P (356.0733)


5-Amino-6-(5-phosphoribitylamino)uracil belongs to the class of organic compounds known as monosaccharide phosphates. These are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 5-Amino-6-(5-phosphoribitylamino)uracil is an extremely weak basic (essentially neutral) compound (based on its pKa). 5-Amino-6-(5-phosphoribitylamino)uracil has been detected, but not quantified in, several different foods, such as sapodilla, kumquats, sacred lotus, Persian limes, and Cascade huckleberries. This could make 5-amino-6-(5-phosphoribitylamino)uracil a potential biomarker for the consumption of these foods. 5-Amino-6-(5-phosphoribitylamino)uracil is an intermediate in riboflavin metabolism. 5-Amino-6-(5-phosphoribitylamino)uracil is the third to last step in the synthesis of 7-hydroxy-6-methyl-8-ribityl lumazine and is converted from 5-amino-6-(5-phosphoribosylamino)uracil via the enzyme 5-amino-6-(5-phosphoribosylamino)uracil reductase (EC 1.1.1.193). It is then converted into 4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine via a hydrolase enzyme (EC 3.1.3.- ). 5-amino-6-(5-phospho-d-ribitylamino)uracil is a member of the class of compounds known as monosaccharide phosphates. Monosaccharide phosphates are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 5-amino-6-(5-phospho-d-ribitylamino)uracil is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 5-amino-6-(5-phospho-d-ribitylamino)uracil can be found in a number of food items such as star fruit, chinese cabbage, mamey sapote, and sapodilla, which makes 5-amino-6-(5-phospho-d-ribitylamino)uracil a potential biomarker for the consumption of these food products. 5-amino-6-(5-phospho-d-ribitylamino)uracil exists in E.coli (prokaryote) and yeast (eukaryote).

   

Tetracenomycin M

Tetracenomycin M

C19H16O7 (356.0896)


   

Fridamycin E

Fridamycin E

C19H16O7 (356.0896)


   

Penicillin g sodium

Penicillin G Sodium Salt

C16H17N2NaO4S (356.0807)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Dihydrohydroxy-O-methylsterigmatocystin

5-hydroxy-11,15-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1(12),2(9),10,14,16,18-hexaen-13-one

C19H16O7 (356.0896)


Dihydrohydroxy-O-methylsterigmatocystin is a mycotoxin produced by Aspergillus parasiticus. Mycotoxin production by Aspergillus parasiticus.

   

Caffeic acid 3-O-glucuronide

(2S,3S,4S,5R,6S)-6-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


Caffeic acid 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

Caffeic acid 4-O-glucuronide

(2S,3S,4S,5R,6S)-6-{4-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


Caffeic acid 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

Caffeoyl C1-glucuronide

(2S,3S,4S,5R,6S)-6-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


Caffeoyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

3,5-Dihydroxycinnamic acid glucuronide

(2R,4R,6R)-6-{3-[(1E)-2-carboxyeth-1-en-1-yl]-5-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

2-[6-Fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]-1-indenyl]acetic acid

2-{5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl}acetic acid

C20H17FO3S (356.0882)


   

Bisdethiobis(methylthio)gliotoxin

6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-1H,2H,3H,4H,5aH,6H,10H,10aH-piperazino[1,2-a]indole-1,4-dione

C15H20N2O4S2 (356.0864)


   

Laquinimod

5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide

C19H17ClN2O3 (356.0928)


C308 - Immunotherapeutic Agent N - Nervous system

   

6-Formylisoophiopogonanone A

3-(1,3-Benzodioxol-5-ylmethyl)-3,4-dihydro-5,7-dihydroxy-8-methyl-4-oxo-2H-1-benzopyran-6-carboxaldehyde

C19H16O7 (356.0896)


   

Butyrolactone II

Methyl 4-hydroxy-2-(4-hydroxybenzyl)-3-(4-hydroxyphenyl)-5-oxo-2,5-dihydro-2-furancarboxylate

C19H16O7 (356.0896)


   

justiflorinol

justiflorinol

C19H16O7 (356.0896)


A natural product found in Piper sanguineispicum.

   

Anthrasesamone C

Anthrasesamone C

C20H17ClO4 (356.0815)


   

Malasseziazole B

Malasseziazole B

C21H12N2O4 (356.0797)


   

4,2-Epoxy-5,7,4,5-tetramethoxy-3-phenylcoumarin

4,2-Epoxy-5,7,4,5-tetramethoxy-3-phenylcoumarin

C19H16O7 (356.0896)


   

Komodoquinone B

Komodoquinone B

C19H16O7 (356.0896)


A member of the class of tetracenequinones that is 7,8,9,10-tetrahydrotetracene-5,12-dione carrying hydroxy groups at positions 1, 6, 8S, 10S and 11 and a methyl group at position 8S. It is the aglycone of komodoquinone A which was isolated from the marine bacterium Streptomyces sp. KS3.

   

Ophiopogonanone C

Ophiopogonanone C

C19H16O7 (356.0896)


   

Brevipsidone C

Brevipsidone C

C19H16O7 (356.0896)


   

5,7,8-Trimethoxy-3,4-methylenedioxyisoflavone

5,7,8-Trimethoxy-3,4-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

Isognaphalin 8-acetate

Isognaphalin 8-acetate

C19H16O7 (356.0896)


   

Isokanugin

2- (1,3-Benzodioxol-5-yl) -3,5,7-trimethoxy-4H-1-benzopyran-4-one

C19H16O7 (356.0896)


   

Ageconyflavone A

2- (1,3-Benzodioxol-5-yl) -5,6,7-trimethoxy-4H-1-benzopyran-4-one

C19H16O7 (356.0896)


   

Dihydrohydroxy-O-methylsterigmatocystin

5-hydroxy-11,15-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0^{2,9}.0^{3,7}.0^{14,19}]icosa-1,9,11,14,16,18-hexaen-13-one

C19H16O7 (356.0896)


   

Iriskumaonin methyl ether

5,3,4-Trimethoxy-6,7-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

5,7,3-Trimethoxy-4,5-methylenedioxyflavone

5,7,3-Trimethoxy-4,5-methylenedioxyflavone

C19H16O7 (356.0896)


   

Milldurone

6,7-Dimethoxy-3- (6-methoxy-1,3-benzodioxol-5-yl) -4H-1-benzopyran-4-one

C19H16O7 (356.0896)


   

6,7,3-Trimethoxy-4,5-methylenedioxyisoflavone

6,7,3-Trimethoxy-4,5-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

7,8,2-Trimethoxy-4,5-methylenedioxyisoflavone

7,8,2-Trimethoxy-4,5-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

8,3,4-Trimethoxy-6,7-methylenedioxyisoflavone

8,3,4-Trimethoxy-6,7-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

Odorantin

5,6,7-Trimethoxy-3,4-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

derrusnin

4,5,7-Trimethoxy-3- (3,4-methylenedioxyphenyl) coumarin

C19H16O7 (356.0896)


   

Hemerocallone

5,2,5-Trimethoxy-6,7-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

Dimethyl gliotoxin

Bisdethiobis(methylthio)gliotoxin

C15H20N2O4S2 (356.0864)


   

Kanugin

3,7-Dimethoxy-2- (7-methoxy-1,3-benzodioxole-5-yl) -4H-1-benzopyran-4-one

C19H16O7 (356.0896)


   

Petalostetin

6,7,8-Trimethoxy-3,4-methylenedioxyisoflavone

C19H16O7 (356.0896)


   
   

2-{3-Phenyl-3-[(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)thio]prop-2-enylidene}malononitrile

2-{3-Phenyl-3-[(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)thio]prop-2-enylidene}malononitrile

C19H12N6S (356.0844)


   

Ethyl 2-{[2-cyano-3-(4-hydroxyphenyl)acryloyl]amino}-4-methylthiophene-3-carboxylate

Ethyl 2-{[2-cyano-3-(4-hydroxyphenyl)acryloyl]amino}-4-methylthiophene-3-carboxylate

C18H16N2O4S (356.0831)


   
   

ZINC49181202

ZINC49181202

C19H16O7 (356.0896)


   

Bis(methylthio)gliotoxin(fr-49175)

Bis(methylthio)gliotoxin(fr-49175)

C15H20N2O4S2 (356.0864)


   

diMe-STA2DC

diMe-STA2DC

C16H20O7S (356.093)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); Could be alkyl homologue of given structure; Digitised from figure: approximate intensities

   

Coumaroyl + C6H9O8 (isomer of 844, 845, 846)

Coumaroyl + C6H9O8 (isomer of 844, 845, 846)

C15H16O10 (356.0743)


Annotation level-3

   

Aldehydoisoophiopogonanone A, 6-

Aldehydoisoophiopogonanone A, 6-

C19H16O7 (356.0896)


   

Erioside

6,8-Dihydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C15H16O10 (356.0743)


Erioside is a natural product found in Morus alba and Lasiosiphon glaucus with data available.

   

5-Hydroxypsorospermin

5-Hydroxypsorospermin

C19H16O7 (356.0896)


   

beta1-Rhodomycinon

beta1-Rhodomycinon

C19H16O7 (356.0896)


   

3,3-dihydroxy-6-O-desmethylterphenyllin

3,3-dihydroxy-6-O-desmethylterphenyllin

C19H16O7 (356.0896)


A para-terphenyl that is 6-O-desmethylterphenyllin substituted by additional hydroxy groups at positions 3 and 3. Isolated from Penicillium chermesinum, it exhibits inhibitory activity against alpha-glucosidase.

   
   

8-hydroxy-3,4-dimeth-oxy-1-methyl-anthraquinone-2-carboxylic acid methyl ester

8-hydroxy-3,4-dimeth-oxy-1-methyl-anthraquinone-2-carboxylic acid methyl ester

C19H16O7 (356.0896)


   

CHEMBL222265

CHEMBL222265

C19H16O7 (356.0896)


   

1-butanoyl-2,4,5-trihydroxy-7-methoxyanthracene-9,10-dione

1-butanoyl-2,4,5-trihydroxy-7-methoxyanthracene-9,10-dione

C19H16O7 (356.0896)


   

demethoxyisodaphnneticin|trans-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-9H-pyrano[2,3-f]-1,4-benzodioxin-9-one

demethoxyisodaphnneticin|trans-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-9H-pyrano[2,3-f]-1,4-benzodioxin-9-one

C19H16O7 (356.0896)


   

2,3,3a,12c-Tetrahydro-3,11-dihydroxy-6-methoxy-3-methyl-7H-furo[2,3:4,5]furo[2,3-c]xanthen-7-one,|psorofebrin

2,3,3a,12c-Tetrahydro-3,11-dihydroxy-6-methoxy-3-methyl-7H-furo[2,3:4,5]furo[2,3-c]xanthen-7-one,|psorofebrin

C19H16O7 (356.0896)


   

mulberroside B

mulberroside B

C15H16O10 (356.0743)


   

Diplotasin

Diplotasin

C19H16O7 (356.0896)


A hydroxyhomoflavonoid that is isochromeno[4,3-b]chromen-7(5H)-one substituted by a hydroxy group at position 4 and methoxy groups at positions 3, 10 and 11. It has been isolated from Mimosa diplotricha.

   

Rugosaflavonoid B

Rugosaflavonoid B

C19H16O7 (356.0896)


   

CHEMBL2408964

CHEMBL2408964

C19H16O7 (356.0896)


   

1,3,6-Trihydroxy-5-methoxy-7-(2-oxo-3-methyl-3-butenyl)-9H-xanthene-9-one

1,3,6-Trihydroxy-5-methoxy-7-(2-oxo-3-methyl-3-butenyl)-9H-xanthene-9-one

C19H16O7 (356.0896)


   

5,7,8-trihydroxycoumarin-5-beta-glucopyranoside

5,7,8-trihydroxycoumarin-5-beta-glucopyranoside

C15H16O10 (356.0743)


   

Neriifolone B

Neriifolone B

C19H16O7 (356.0896)


   

5,7-Dihydroxy-3-(4-hydroxy-1,3-benzodioxole-5-ylmethyl)-6,8-dimethyl-4H-1-benzopyran-4-one

5,7-Dihydroxy-3-(4-hydroxy-1,3-benzodioxole-5-ylmethyl)-6,8-dimethyl-4H-1-benzopyran-4-one

C19H16O7 (356.0896)


   

Cleomiscosin A

Cleomiscosin A

C19H16O7 (356.0896)


   

demethoxydaphneticin

demethoxydaphneticin

C19H16O7 (356.0896)


   

5,6,7-Trimethoxy-3,4-methylenedioxyisoflavone

5,6,7-Trimethoxy-3,4-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

6a,12a-Dehydrosermundone

6a,12a-Dehydrosermundone

C19H16O7 (356.0896)


   
   

9,10-Dihydro-7-hydroxy-3,8-dimethoxy-1-methyl-9,10-dioxo-2-anthracenecarboxylic acid methyl ester

9,10-Dihydro-7-hydroxy-3,8-dimethoxy-1-methyl-9,10-dioxo-2-anthracenecarboxylic acid methyl ester

C19H16O7 (356.0896)


   

DTXSID40788618

DTXSID40788618

C19H16O7 (356.0896)


   

6-formyl-isoophiopogonanone A

3-(1,3-Benzodioxol-5-ylmethyl)-3,4-dihydro-5,7-dihydroxy-8-methyl-4-oxo-2H-1-benzopyran-6-carboxaldehyde

C19H16O7 (356.0896)


   

Sulindac (Clinoril)

Sulindac (Clinoril)

C20H17FO3S (356.0882)


   

Butyrolactone II_130093

Butyrolactone II_130093

C19H16O7 (356.0896)


   

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate

NCGC00180622-03!methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate

C19H16O7 (356.0896)


   

2-hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid

NCGC00385404-01!2-hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid

C16H20O7S (356.093)


   

7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one

NCGC00380487-01!7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one

C19H16O7 (356.0896)


   

C15H20N2O4S2_Pyrazino[1,2-a]indole-1,4-dione, 2,3,5a,6,10,10a-hexahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylthio)-, (3R,5aS,6S,10aR)

NCGC00380667-01_C15H20N2O4S2_Pyrazino[1,2-a]indole-1,4-dione, 2,3,5a,6,10,10a-hexahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylthio)-, (3R,5aS,6S,10aR)-

C15H20N2O4S2 (356.0864)


   

7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one

7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one

C19H16O7 (356.0896)


   

Bisdethiobis(methylthio)gliotoxin

Bisdethiobis(methylthio)gliotoxin

C15H20N2O4S2 (356.0864)


D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

   

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate

C19H16O7 (356.0896)


   

Sulindac

Sulindac aka 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid

C20H17FO3S (356.0882)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

Coumaroyl + C6H9O8 (isomer of 843, 844, 846)

Coumaroyl + C6H9O8 (isomer of 843, 844, 846)

C15H16O10 (356.0743)


Annotation level-3

   

Coumaroyl + C6H9O8 (isomer of 843, 845, 846)

Coumaroyl + C6H9O8 (isomer of 843, 845, 846)

C15H16O10 (356.0743)


Annotation level-3

   

Coumaroyl + C6H9O8 (isomer of 843, 844, 845)

Coumaroyl + C6H9O8 (isomer of 843, 844, 845)

C15H16O10 (356.0743)


Annotation level-3

   

7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one [IIN-based on: CCMSLIB00000848673]

NCGC00380487-01!7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one [IIN-based on: CCMSLIB00000848673]

C19H16O7 (356.0896)


   

2-hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid [IIN-based on: CCMSLIB00000848339]

NCGC00385404-01!2-hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid [IIN-based on: CCMSLIB00000848339]

C16H20O7S (356.093)


   

2-hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid [IIN-based: Match]

NCGC00385404-01!2-hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid [IIN-based: Match]

C16H20O7S (356.093)


   

7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one [IIN-based: Match]

NCGC00380487-01!7,9-dimethoxy-6-(4-methoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one [IIN-based: Match]

C19H16O7 (356.0896)


   

3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-g]chromen-7-one

3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-g]chromen-7-one

C19H16O7 (356.0896)


   

bisdethiobis(methylthio)gliotoxin_major

bisdethiobis(methylthio)gliotoxin_major

C15H20N2O4S2 (356.0864)


   

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate_major

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate_major

C19H16O7 (356.0896)


   

Odoratine

5,6,7-Trimethoxy-3,4-methylenedioxyisoflavone

C19H16O7 (356.0896)


   

Thr-Asp-OH

(S)-2-(3-((R)-2-hydroxypropoxy)-4-nitrobenzamido)succinic acid

C14H16N2O9 (356.0856)


   

Caffeic acid 3-O-glucuronide

(2S,3S,4S,5R,6S)-6-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

Caffeic acid 4-O-glucuronide

(2S,3S,4S,5R,6S)-6-{4-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

Caffeoyl C1-glucuronide

(2S,3S,4S,5R,6S)-6-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

7,9-Dimethoxy-6-(4-methoxyphenyl)-8H-[1,3]dioxolo[4,5-g]chromen-8-one

7,9-Dimethoxy-6-(4-methoxyphenyl)-8H-[1,3]dioxolo[4,5-g]chromen-8-one

C19H16O7 (356.0896)


   

4-(6-Bromo-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester

4-(6-Bromo-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester

C15H21BrN2O3 (356.0735)


   

6-amino-4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinoline-3-carbonitrile

6-amino-4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinoline-3-carbonitrile

C18H14ClFN4O (356.084)


   

N-[[4-[5-methyl-3-phenylisoxazol-4-yl]phenyl]sulfonyl]acetamide

N-[[4-[5-methyl-3-phenylisoxazol-4-yl]phenyl]sulfonyl]acetamide

C18H16N2O4S (356.0831)


   

3,7-o-diacetylpinobanksin

3,7-o-diacetylpinobanksin

C19H16O7 (356.0896)


   
   

2-CARBETHOXY-5,7-DIHYDROXY-4-METHOXYISOFLAVONE

2-CARBETHOXY-5,7-DIHYDROXY-4-METHOXYISOFLAVONE

C19H16O7 (356.0896)


   

1,6-anhydro-3,4-o-isopropylidene-2-tosyl-b-d-galactopyranose

1,6-anhydro-3,4-o-isopropylidene-2-tosyl-b-d-galactopyranose

C16H20O7S (356.093)


   

Ferric acetylacetonate

Ferric acetylacetonate

C15H24FeO6 (356.0922)


   

PENTAMETHYL CYCLOPENTADIENE-1,2,3,4,5-PENTACARBOXYLATE

PENTAMETHYL CYCLOPENTADIENE-1,2,3,4,5-PENTACARBOXYLATE

C15H16O10 (356.0743)


   

Difluoro(triphenylphosphonio)acetate

Difluoro(triphenylphosphonio)acetate

C20H15F2O2P (356.0778)


   

AICAR phosphate

AICAR phosphate

C9H17N4O9P (356.0733)


AICAR phosphate (Acadesine phosphate) is an adenosine analog and a AMPK activator. AICAR phosphate regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR phosphate is also an autophagy, YAP and mitophagy inhibitor[1][2]. AICAR phosphate (Acadesine phosphate) is an adenosine analog and a AMPK activator. AICAR phosphate regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR phosphate is also an autophagy, YAP and mitophagy inhibitor[1][2]. AICAR phosphate (Acadesine phosphate) is an adenosine analog and a AMPK activator. AICAR phosphate regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR phosphate is also an autophagy, YAP and mitophagy inhibitor[1][2].

   

N-methyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide

N-methyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide

C17H16N4OS2 (356.0765)


   

4-(2-methoxyphenoxy)-N-(3-pyridinyl)benzenesulfonamide

4-(2-methoxyphenoxy)-N-(3-pyridinyl)benzenesulfonamide

C18H16N2O4S (356.0831)


   

(5Z)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-2-(4-methoxyanilino)-1,3-thiazol-4-one

(5Z)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-2-(4-methoxyanilino)-1,3-thiazol-4-one

C18H16N2O4S (356.0831)


   

deacetoxycephalosporin C(1-)

deacetoxycephalosporin C(1-)

C14H18N3O6S- (356.0916)


Conjugate base of deacetoxycephalosporin C

   

D-pantetheine 4-phosphate(2-)

D-pantetheine 4-phosphate(2-)

C11H21N2O7PS-2 (356.0807)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

alpha-Ribazole 5-phosphate(2-)

alpha-Ribazole 5-phosphate(2-)

C14H17N2O7P-2 (356.0773)


   

gaudimycin B

gaudimycin B

C19H16O7 (356.0896)


   

Pantetheine 4-phosphate(2-)

Pantetheine 4-phosphate(2-)

C11H21N2O7PS-2 (356.0807)


   

3-exomethylenecephalosporin-C

3-exomethylenecephalosporin-C

C14H18N3O6S- (356.0916)


   

(3S,7R)-11-methoxy-3,7-dimethyl-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,4,9,11,13(18)-pentaene-17,19-dione

(3S,7R)-11-methoxy-3,7-dimethyl-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,4,9,11,13(18)-pentaene-17,19-dione

C19H16O7 (356.0896)


   

3,5-Dihydroxycinnamic acid glucuronide

3,5-Dihydroxycinnamic acid glucuronide

C15H16O10 (356.0743)


   

Methyl (2s)-4-Hydroxy-3-(4-Hydroxyphenyl)-2-[(4-Hydroxyphenyl)methyl]-5-Oxo-2,5-Dihydrofuran-2-Carboxylate

Methyl (2s)-4-Hydroxy-3-(4-Hydroxyphenyl)-2-[(4-Hydroxyphenyl)methyl]-5-Oxo-2,5-Dihydrofuran-2-Carboxylate

C19H16O7 (356.0896)


   

2-[[2-(6-oxo-1-cyclohexa-2,4-dienylidene)-3H-1,3,4-oxadiazol-5-yl]thio]acetic acid (2,6-dimethylphenyl) ester

2-[[2-(6-oxo-1-cyclohexa-2,4-dienylidene)-3H-1,3,4-oxadiazol-5-yl]thio]acetic acid (2,6-dimethylphenyl) ester

C18H16N2O4S (356.0831)


   

N-[(5-chloro-8-hydroxy-7-quinolinyl)-(4-methoxyphenyl)methyl]acetamide

N-[(5-chloro-8-hydroxy-7-quinolinyl)-(4-methoxyphenyl)methyl]acetamide

C19H17ClN2O3 (356.0928)


   

methyl 4-{[2-(methylsulfanyl)-6,7-dihydro-1H-[1,4]dioxino[2,3-f]benzimidazol-1-yl]carbonyl}phenyl ether

methyl 4-{[2-(methylsulfanyl)-6,7-dihydro-1H-[1,4]dioxino[2,3-f]benzimidazol-1-yl]carbonyl}phenyl ether

C18H16N2O4S (356.0831)


   

5-Chloro-2-(3,5-dimethylphenyl)-4-(4-methoxyphenoxy)-3-pyridazinone

5-Chloro-2-(3,5-dimethylphenyl)-4-(4-methoxyphenoxy)-3-pyridazinone

C19H17ClN2O3 (356.0928)


   

4-[({[3-(4-Methoxyphenyl)acryloyl]amino}carbonothioyl)amino]benzoic acid

4-[({[3-(4-Methoxyphenyl)acryloyl]amino}carbonothioyl)amino]benzoic acid

C18H16N2O4S (356.0831)


   

5-(4-Hydroxy-3-methoxy-benzylidene)-2-(2-methoxy-phenylimino)-thiazolidin-4-one

5-(4-Hydroxy-3-methoxy-benzylidene)-2-(2-methoxy-phenylimino)-thiazolidin-4-one

C18H16N2O4S (356.0831)


   

5-Chloro-4-(4-ethoxyphenoxy)-2-(4-methylphenyl)-3-pyridazinone

5-Chloro-4-(4-ethoxyphenoxy)-2-(4-methylphenyl)-3-pyridazinone

C19H17ClN2O3 (356.0928)


   

5-Chloro-2-(4-ethylphenyl)-4-(4-methoxyphenoxy)-3-pyridazinone

5-Chloro-2-(4-ethylphenyl)-4-(4-methoxyphenoxy)-3-pyridazinone

C19H17ClN2O3 (356.0928)


   

2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-7H-pyrano[2,3-g][1,4]benzodioxin-7-one

2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-7H-pyrano[2,3-g][1,4]benzodioxin-7-one

C19H16O7 (356.0896)


A guaiacyl lignin obtained by formal cyclocodensation between guaiacylglycerol and esculetin. It is found in Arabidopsis thaliana.

   

11-hydroxy-O-methyldihydrosterigmatocystin

11-hydroxy-O-methyldihydrosterigmatocystin

C19H16O7 (356.0896)


A sterigmatocystin that is the 11-hydroxy-8-O-methyl derivative of dihydrosterigmatocystin.

   

2-Hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid

2-Hydroxy-3-[2-(7-hydroxy-5-methoxy-2-methyl-4-oxo-2,3-dihydrochromen-8-yl)ethylsulfanyl]propanoic acid

C16H20O7S (356.093)


   

5-Amino-6-(5-phospho-D-ribitylamino)uracil

5-Amino-6-(5-phospho-D-ribitylamino)uracil

C9H17N4O9P (356.0733)


5-O-Phosphono-D-ribitol in which the hydroxy group at position 1 is substituted by the 6-amino group of 5,6-diaminopyrimidine-2,4(1H,3H)-dione.

   

Laquinimod

Laquinimod

C19H17ClN2O3 (356.0928)


C308 - Immunotherapeutic Agent N - Nervous system

   

D-pantetheine 4-phosphate(2-)

D-pantetheine 4-phosphate(2-)

C11H21N2O7PS (356.0807)


Pantetheine 4-phosphate(2-) with D (R) configuration at the 2 position. The dianion formed from D-pantetheine 4-phosphate by deprotonation of the phosphate group; major microspecies at pH 7.3.

   

Pantetheine 4-phosphate(2-)

Pantetheine 4-phosphate(2-)

C11H21N2O7PS (356.0807)


   

alpha-Ribazole 5-phosphate(2-)

alpha-Ribazole 5-phosphate(2-)

C14H17N2O7P (356.0773)


Dianion of alpha-ribazole 5-phosphate arising from deprotonation of the phosphate OH groups; major species at pH 7.3.

   
   

AminoPhospho-ribitylamino-uracil

AminoPhospho-ribitylamino-uracil

C9H17N4O9P (356.0733)


   

(2r,3r)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

(2r,3r)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

C19H16O7 (356.0896)


   

(2r)-1,4-bis(2h-1,3-benzodioxol-5-yl)-2-(hydroxymethyl)butane-1,4-dione

(2r)-1,4-bis(2h-1,3-benzodioxol-5-yl)-2-(hydroxymethyl)butane-1,4-dione

C19H16O7 (356.0896)


   

6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indole-1,4-dione

6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indole-1,4-dione

C15H20N2O4S2 (356.0864)


   

10-hydroxy-2-[2-(hydroxymethyl)oxiran-2-yl]-5-methoxy-1h,2h-furo[2,3-c]xanthen-6-one

10-hydroxy-2-[2-(hydroxymethyl)oxiran-2-yl]-5-methoxy-1h,2h-furo[2,3-c]xanthen-6-one

C19H16O7 (356.0896)


   

1,6,8,10,11-pentahydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

1,6,8,10,11-pentahydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

C19H16O7 (356.0896)


   

6,8-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

6,8-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

(8s,10s)-1,6,8,10,11-pentahydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

(8s,10s)-1,6,8,10,11-pentahydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

C19H16O7 (356.0896)


   

15-hydroxy-5,11-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

15-hydroxy-5,11-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

C19H16O7 (356.0896)


   

5,7-dihydroxy-3-[(4-hydroxy-2h-1,3-benzodioxol-5-yl)methyl]-6,8-dimethylchromen-4-one

5,7-dihydroxy-3-[(4-hydroxy-2h-1,3-benzodioxol-5-yl)methyl]-6,8-dimethylchromen-4-one

C19H16O7 (356.0896)


   

(3s)-3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-6-methyl-4-oxo-2,3-dihydro-1-benzopyran-8-carbaldehyde

(3s)-3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-6-methyl-4-oxo-2,3-dihydro-1-benzopyran-8-carbaldehyde

C19H16O7 (356.0896)


   

2'-hydroxymethylophiopogonone a

NA

C19H16O7 (356.0896)


{"Ingredient_id": "HBIN005814","Ingredient_name": "2'-hydroxymethylophiopogonone a","Alias": "NA","Ingredient_formula": "C19H16O7","Ingredient_Smile": "CC1=C(C2=C(C(=C1O)C)OC=C(C2=O)CC3=C(C4=C(C=C3)OCO4)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10508","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(4ar,6r,12bs)-4a,6,8,12b-tetrahydroxy-3-methyl-5,6-dihydro-4h-tetraphene-1,7,12-trione

(4ar,6r,12bs)-4a,6,8,12b-tetrahydroxy-3-methyl-5,6-dihydro-4h-tetraphene-1,7,12-trione

C19H16O7 (356.0896)


   

methyl 1,3-dihydroxy-2,5-bis(4-hydroxyphenyl)-4-oxocyclopent-2-ene-1-carboxylate

methyl 1,3-dihydroxy-2,5-bis(4-hydroxyphenyl)-4-oxocyclopent-2-ene-1-carboxylate

C19H16O7 (356.0896)


   

7,9,13-trihydroxy-5-methyl-19-oxapentacyclo[8.8.1.0¹,¹⁰.0²,⁷.0¹²,¹⁷]nonadeca-4,12,14,16-tetraene-3,11,18-trione

7,9,13-trihydroxy-5-methyl-19-oxapentacyclo[8.8.1.0¹,¹⁰.0²,⁷.0¹²,¹⁷]nonadeca-4,12,14,16-tetraene-3,11,18-trione

C19H16O7 (356.0896)


   

7,11-dihydroxy-6-methoxy-4,4-dimethyl-3h-1,5-dioxatetraphene-2,10-dione

7,11-dihydroxy-6-methoxy-4,4-dimethyl-3h-1,5-dioxatetraphene-2,10-dione

C19H16O7 (356.0896)


   

3-[(2-acetyl-3,5-dihydroxyphenyl)methyl]-8-hydroxy-6-methoxyisochromen-1-one

3-[(2-acetyl-3,5-dihydroxyphenyl)methyl]-8-hydroxy-6-methoxyisochromen-1-one

C19H16O7 (356.0896)


   

8-acetyl-2-(3,4-dihydroxyphenyl)-6,7-dimethoxychromen-4-one

8-acetyl-2-(3,4-dihydroxyphenyl)-6,7-dimethoxychromen-4-one

C19H16O7 (356.0896)


   

3,5,13,14-tetramethoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one

3,5,13,14-tetramethoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one

C19H16O7 (356.0896)


   

5,7-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

5,7-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

methyl 7-hydroxy-3,8-dimethoxy-1-methyl-9,10-dioxoanthracene-2-carboxylate

methyl 7-hydroxy-3,8-dimethoxy-1-methyl-9,10-dioxoanthracene-2-carboxylate

C19H16O7 (356.0896)


   

methyl 8-hydroxy-3,4-dimethoxy-1-methyl-9,10-dioxoanthracene-2-carboxylate

methyl 8-hydroxy-3,4-dimethoxy-1-methyl-9,10-dioxoanthracene-2-carboxylate

C19H16O7 (356.0896)


   

(1r,2r,7s,9r,10s)-7,9,13-trihydroxy-5-methyl-19-oxapentacyclo[8.8.1.0¹,¹⁰.0²,⁷.0¹²,¹⁷]nonadeca-4,12,14,16-tetraene-3,11,18-trione

(1r,2r,7s,9r,10s)-7,9,13-trihydroxy-5-methyl-19-oxapentacyclo[8.8.1.0¹,¹⁰.0²,⁷.0¹²,¹⁷]nonadeca-4,12,14,16-tetraene-3,11,18-trione

C19H16O7 (356.0896)


   

1,6,7,8,11-pentahydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

1,6,7,8,11-pentahydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

C19H16O7 (356.0896)


   

(4e)-4-[(3,4-dihydroxyphenyl)methylidene]-2-(3-hydroxy-4-methylphenyl)-5-oxooxolane-3-carboxylic acid

(4e)-4-[(3,4-dihydroxyphenyl)methylidene]-2-(3-hydroxy-4-methylphenyl)-5-oxooxolane-3-carboxylic acid

C19H16O7 (356.0896)


   

5,7-dimethoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

5,7-dimethoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

C19H16O7 (356.0896)


   

7,8-dimethoxy-3-(6-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

7,8-dimethoxy-3-(6-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

C19H16O7 (356.0896)


   

(2s,3s)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

(2s,3s)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

C19H16O7 (356.0896)


   

6,8-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

6,8-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

{12-formyl-5h,11h-indolo[3,2-b]carbazol-6-yl}(oxo)acetic acid

{12-formyl-5h,11h-indolo[3,2-b]carbazol-6-yl}(oxo)acetic acid

C21H12N2O4 (356.0797)


   

5-(3,5,8-trihydroxy-9,10-dioxoanthracen-1-yl)pentanoic acid

5-(3,5,8-trihydroxy-9,10-dioxoanthracen-1-yl)pentanoic acid

C19H16O7 (356.0896)


   

(3s,5s,7s)-15-hydroxy-5,11-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

(3s,5s,7s)-15-hydroxy-5,11-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

C19H16O7 (356.0896)


   

2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

C19H16O7 (356.0896)


   

3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

C19H16O7 (356.0896)


   

3-(4,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-7-methoxychromen-4-one

3-(4,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-7-methoxychromen-4-one

C19H16O7 (356.0896)


   

3-[2-(2,4-dihydroxy-6-methylphenyl)-2-oxoethyl]-8-hydroxy-6-methoxyisochromen-1-one

3-[2-(2,4-dihydroxy-6-methylphenyl)-2-oxoethyl]-8-hydroxy-6-methoxyisochromen-1-one

C19H16O7 (356.0896)


   

11-hydroxy-2,3,9-trimethoxy-6h-5,7-dioxatetraphen-12-one

11-hydroxy-2,3,9-trimethoxy-6h-5,7-dioxatetraphen-12-one

C19H16O7 (356.0896)


   

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-oxofuran-2-carboxylate

C19H16O7 (356.0896)


   

1-hydroxy-3,7,8-trimethoxy-10h-5,11-dioxatetraphen-12-one

1-hydroxy-3,7,8-trimethoxy-10h-5,11-dioxatetraphen-12-one

C19H16O7 (356.0896)


   

3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-8-methyl-4-oxo-2,3-dihydro-1-benzopyran-6-carbaldehyde

3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-8-methyl-4-oxo-2,3-dihydro-1-benzopyran-6-carbaldehyde

C19H16O7 (356.0896)


   

2-chloro-1,4-dihydroxy-3-(4-methylpent-3-en-1-yl)anthracene-9,10-dione

2-chloro-1,4-dihydroxy-3-(4-methylpent-3-en-1-yl)anthracene-9,10-dione

C20H17ClO4 (356.0815)


   

(3r,5as,6s,10ar)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indole-1,4-dione

(3r,5as,6s,10ar)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indole-1,4-dione

C15H20N2O4S2 (356.0864)


   

(2s)-1,4-bis(2h-1,3-benzodioxol-5-yl)-2-(hydroxymethyl)butane-1,4-dione

(2s)-1,4-bis(2h-1,3-benzodioxol-5-yl)-2-(hydroxymethyl)butane-1,4-dione

C19H16O7 (356.0896)


   

7,8-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

7,8-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

(3s,6r,7r)-6,18-dihydroxy-11-methoxy-6-methyl-4,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

(3s,6r,7r)-6,18-dihydroxy-11-methoxy-6-methyl-4,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

C19H16O7 (356.0896)


   

(3r)-3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-6-methyl-4-oxo-2,3-dihydro-1-benzopyran-8-carbaldehyde

(3r)-3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-6-methyl-4-oxo-2,3-dihydro-1-benzopyran-8-carbaldehyde

C19H16O7 (356.0896)


   

2-(2h-1,3-benzodioxol-5-yl)-5,7,8-trimethoxychromen-4-one

2-(2h-1,3-benzodioxol-5-yl)-5,7,8-trimethoxychromen-4-one

C19H16O7 (356.0896)


   

(2s,3s)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

(2s,3s)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

C19H16O7 (356.0896)


   

6,7-dimethoxy-3-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

6,7-dimethoxy-3-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

C19H16O7 (356.0896)


   

4-(3,4-dihydroxyphenyl)-3-methoxy-[1,1'-biphenyl]-2,3',4',6-tetrol

4-(3,4-dihydroxyphenyl)-3-methoxy-[1,1'-biphenyl]-2,3',4',6-tetrol

C19H16O7 (356.0896)


   

(3s,5r,7s)-15-hydroxy-5,11-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

(3s,5r,7s)-15-hydroxy-5,11-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

C19H16O7 (356.0896)


   

5,12-dihydroxy-4-methoxy-16,16-dimethyl-2,9,15-trioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),3(8),4,6,11,13,17-heptaen-10-one

5,12-dihydroxy-4-methoxy-16,16-dimethyl-2,9,15-trioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),3(8),4,6,11,13,17-heptaen-10-one

C19H16O7 (356.0896)


   

6,7-dimethoxy-3-(4-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

6,7-dimethoxy-3-(4-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

C19H16O7 (356.0896)


   

(3r,5as,10ar)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indole-1,4-dione

(3r,5as,10ar)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indole-1,4-dione

C15H20N2O4S2 (356.0864)


   

(3r,6ar,7s,10br)-7-hydroxy-3-(hydroxymethyl)-2-methyl-3,10b-bis(methylsulfanyl)-6h,6ah,7h-pyrazino[2,1-a]isoindole-1,4-dione

(3r,6ar,7s,10br)-7-hydroxy-3-(hydroxymethyl)-2-methyl-3,10b-bis(methylsulfanyl)-6h,6ah,7h-pyrazino[2,1-a]isoindole-1,4-dione

C15H20N2O4S2 (356.0864)


   

(3s)-3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-8-methyl-4-oxo-2,3-dihydro-1-benzopyran-6-carbaldehyde

(3s)-3-(2h-1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-8-methyl-4-oxo-2,3-dihydro-1-benzopyran-6-carbaldehyde

C19H16O7 (356.0896)


   

7,8-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

7,8-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

6,18-dihydroxy-11-methoxy-6-methyl-4,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

6,18-dihydroxy-11-methoxy-6-methyl-4,8,20-trioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

C19H16O7 (356.0896)


   

3-ethyl-1-hydroxy-6,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid

3-ethyl-1-hydroxy-6,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid

C19H16O7 (356.0896)